These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15176421)

  • 1. Cardiac channelopathies: from men to mice.
    Charpentier F; Demolombe S; Escande D
    Ann Med; 2004; 36 Suppl 1():28-34. PubMed ID: 15176421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
    Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
    Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular genetics in the hereditary form of long QT syndrome].
    Georgijević Milić L
    Med Pregl; 2000; 53(1-2):51-4. PubMed ID: 10953551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models of SCN5A-related cardiac arrhythmias.
    Charpentier F; Bourgé A; Mérot J
    Prog Biophys Mol Biol; 2008; 98(2-3):230-7. PubMed ID: 19041666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac sodium channelopathies.
    Amin AS; Asghari-Roodsari A; Tan HL
    Pflugers Arch; 2010 Jul; 460(2):223-37. PubMed ID: 20091048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The implications of genetic mutations in the sodium channel gene (SCN5A).
    Moric E; Herbert E; Trusz-Gluza M; Filipecki A; Mazurek U; Wilczok T
    Europace; 2003 Oct; 5(4):325-34. PubMed ID: 14753626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel LQT-3 mutation disrupts an inactivation gate complex with distinct rate-dependent phenotypic consequences.
    Bankston JR; Sampson KJ; Kateriya S; Glaaser IW; Malito DL; Chung WK; Kass RS
    Channels (Austin); 2007; 1(4):273-80. PubMed ID: 18708744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LQT syndromes--current status of molecular mechanisms.
    Schulze-Bahr E; Wedekind H; Haverkamp W; Borggrefe M; Assmann G; Breithardt G; Funke H
    Z Kardiol; 1999 Apr; 88(4):245-54. PubMed ID: 10408028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of genetic studies in lethal inherited cardiac arrhythmias.
    Shimizu W
    Circ J; 2008 Dec; 72(12):1926-36. PubMed ID: 18981593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome.
    Nuyens D; Stengl M; Dugarmaa S; Rossenbacker T; Compernolle V; Rudy Y; Smits JF; Flameng W; Clancy CE; Moons L; Vos MA; Dewerchin M; Benndorf K; Collen D; Carmeliet E; Carmeliet P
    Nat Med; 2001 Sep; 7(9):1021-7. PubMed ID: 11533705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of the long QT syndrome: impact on management.
    Priori SG; Napolitano C; Paganini V; Cantù F; Schwartz PJ
    Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCN5A channelopathies--an update on mutations and mechanisms.
    Zimmer T; Surber R
    Prog Biophys Mol Biol; 2008; 98(2-3):120-36. PubMed ID: 19027780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long QT syndrome].
    Nakajima T; Kaneko Y; Taniguchi Y; Nagai R
    Nihon Rinsho; 1996 Mar; 54(3):776-81. PubMed ID: 8904236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenic consequences of Na+ channel mutations in the transmurally heterogeneous mammalian left ventricle: analysis of the I1768V SCN5A mutation.
    Flaim SN; Giles WR; McCulloch AD
    Heart Rhythm; 2007 Jun; 4(6):768-78. PubMed ID: 17556201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.
    Zareba W; Moss AJ; Locati EH; Lehmann MH; Peterson DR; Hall WJ; Schwartz PJ; Vincent GM; Priori SG; Benhorin J; Towbin JA; Robinson JL; Andrews ML; Napolitano C; Timothy K; Zhang L; Medina A;
    J Am Coll Cardiol; 2003 Jul; 42(1):103-9. PubMed ID: 12849668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential calcium sensitivity in Na
    Abdelsayed M; Baruteau AE; Gibbs K; Sanatani S; Krahn AD; Probst V; Ruben PC
    J Physiol; 2017 Sep; 595(18):6165-6186. PubMed ID: 28734073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long QT syndromes: genetic basis and clinical implications.
    Chiang CE; Roden DM
    J Am Coll Cardiol; 2000 Jul; 36(1):1-12. PubMed ID: 10898405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome.
    Clancy CE; Tateyama M; Kass RS
    J Clin Invest; 2002 Nov; 110(9):1251-62. PubMed ID: 12417563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac channelopathies associated with infantile fatal ventricular arrhythmias: from the cradle to the bench.
    Kato K; Makiyama T; Wu J; Ding WG; Kimura H; Naiki N; Ohno S; Itoh H; Nakanishi T; Matsuura H; Horie M
    J Cardiovasc Electrophysiol; 2014 Jan; 25(1):66-73. PubMed ID: 24112685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.
    Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M
    J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.